Urinary cysteinyl leukotriene E4 level and therapeutic response to montelukast in children with mild obstructive sleep apnea

Antileukotriene has been used for alleviating disease severity in children with adenotonsillar hypertrophy (ATH) and mild obstructive sleep apnea (OSA). Previous study showed the relationship between urinary cysteinyl leukotriene E₄ (uLTE₄) level and therapeutic response to montelukast in asthmatic...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Asian Pacific journal of allergy and immunology 2017-12, Vol.35 (4), p.233-238
Hauptverfasser:	Sunkonkit, Kanokkarn, Sritippayawan, Suchada, Veeravikrom, Montida, Deerojanawong, Jitladda, Prapphal, Nuanchan
Format:	Artikel
Sprache:	eng
Schlagworte:	Acetates - therapeutic use Adolescent Anti-Asthmatic Agents - therapeutic use Apnea Asthma Biomarkers, Pharmacological - urine Child Child, Preschool Children Children & youth Creatinine Creatinine - blood Disease Progression Drug therapy Female Humans Hypertrophy Leukotriene E4 - urine Male Montelukast Predictive Value of Tests Prognosis Quality of life Quinolines - therapeutic use Sleep Sleep apnea Sleep Apnea, Obstructive - diagnosis Sleep Apnea, Obstructive - drug therapy Sleep disorders
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!